Page 115 - Read Online

Watson et al. J Transl Genet Genom 2020;4:188-202 I http://dx.doi.org/10.20517/jtgg.2020.31 Page 201

55. Kumar KR, Cowley MJ, Davis RL. Next-generation sequencing and emerging technologies. Semin Thromb Hemost 2019;45:661-73.
56. Niyazov DM, Kahler SG, Frye RE. Primary mitochondrial disease and secondary mitochondrial dysfunction: importance of distinction
for diagnosis and treatment. Mol Syndromol 2016;7:122-37.
57. Raymond FL, Horvath R, Chinnery PF. First-line genomic diagnosis of mitochondrial disorders. Nat Rev Genet 2018;19:399-400.
58. Parikh S, Goldstein A, Koenig MK, Scaglia F, Enns GM, et al. Diagnosis and management of mitochondrial disease: a consensus
statement from the Mitochondrial Medicine Society. Genet Med 2015;17:689-701.
59. Sue CM, Quigley A, Katsabanis S, Kapsa R, Crimmins DS, et al. Detection of MELAS A3243G point mutation in muscle, blood and hair
follicles. J Neurol Sci 1998;161:36-9.
60. Broomfield A, Sweeney MG, Woodward CE, Fratter C, Morris AM, et al. Paediatric single mitochondrial DNA deletion disorders: an
overlapping spectrum of disease. J Inherit Metab Dis 2015;38:445-57.
61. DaRe JT, Vasta V, Penn J, Tran NTB, Hahn SH. Targeted exome sequencing for mitochondrial disorders reveals high genetic
heterogeneity. BMC Med Genet 2013;14:118.
62. Rodenburg RJ, Schoonderwoerd GC, Tiranti V, Taylor RW, Rötig A, et al. A multi-center comparison of diagnostic methods for the
biochemical evaluation of suspected mitochondrial disorders. Mitochondrion 2013;13:36-43.
63. Phadke R. Myopathology of adult and paediatric mitochondrial diseases. J Clin Med 2017;6:64.
64. Gellerich FN, Mayr JA, Reuter S, Sperl W, Zierz S. The problem of interlab variation in methods for mitochondrial disease diagnosis:
enzymatic measurement of respiratory chain complexes. Mitochondrion 2004;4:427-39.
65. Medja F, Allouche S, Frachon P, Jardel C, Malgat M, et al. Development and implementation of standardized respiratory chain
spectrophotometric assays for clinical diagnosis. Mitochondrion 2009;9:331-9.
66. Dimmock DP, Lawlor MW. Presentation and diagnostic evaluation of mitochondrial disease. Pediatr Clin North Am 2017;64:161-71.
67. Molnar MJ, Kovacs GG. Mitochondrial diseases. Handb Clin Neurol 2017;145:147-55.
68. Suomalainen A. Biomarkers for mitochondrial respiratory chain disorders. J Inherit Metab Dis 2011;34:277-82.
69. Oglesbee D, Freedenberg D, Kramer KA, Anderson BD, Hahn SH. Normal muscle respiratory chain enzymes can complicate
mitochondrial disease diagnosis. Pediatr Neurol 2006;35:289-92.
70. Stenton SL, Prokisch H. Advancing genomic approaches to the molecular diagnosis of mitochondrial disease. Essays biochem
2018;62:399-408.
71. Vasta V, Merritt JL, 2nd, Saneto RP, Hahn SH. Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum.
Pediatr Int 2012;54:585-601.
72. Plutino M, Chaussenot A, Rouzier C, Ait-El-Mkadem S, Fragaki K, et al. Targeted next generation sequencing with an extended gene
panel does not impact variant detection in mitochondrial diseases. BMC Med Genet 2018;19:57.
73. Lieber DS, Calvo SE, Shanahan K, Slate NG, Liu S, et al. Targeted exome sequencing of suspected mitochondrial disorders. Neurology
2013;80:1762-70.
74. Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, et al. Molecular diagnosis of infantile mitochondrial disease with targeted
next-generation sequencing. Sci Transl Med 2012;4:118ra10.
75. Wagner M, Berutti R, Lorenz-Depiereux B, Graf E, Eckstein G, et al. Mitochondrial DNA mutation analysis from exome sequencing - A
more holistic approach in diagnostics of suspected mitochondrial disease. J Inherit Metab Dis 2019;42:909-17.
76. Falk MJ, Pierce EA, Consugar M, Xie MH, Guadalupe M, et al. Mitochondrial disease genetic diagnostics: optimized whole-exome
analysis for all MitoCarta nuclear genes and the mitochondrial genome. Discov Med 2012;14:389-99.
77. Abicht A, Scharf F, Kleinle S, Schön U, Holinski-Feder E, et al. Mitochondrial and nuclear disease panel (Mito-aND-Panel): combined
sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method. Mol Genet Genomic Med
2018;6:1188-98.
78. Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol 2017;241:236-50.
79. Murayama K, Shimura M, Liu Z, Okazaki Y, Ohtake A. Recent topics: the diagnosis, molecular genesis, and treatment of mitochondrial
diseases. J Hum Genet 2019;64:113-25.
80. Stark Z, Tan TY, Chong B, Brett GR, Yap P, et al. A prospective evaluation of whole-exome sequencing as a first-tier molecular test in
infants with suspected monogenic disorders. Genet Med 2016;18:1090-6.
81. Richards S, Aziz N, Bale S, Bick D, Das S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus
recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med
2015;17:405-24.
82. McCormick EM, Muraresku CC, Falk MJ. Mitochondrial genomics: a complex field now coming of age. Curr Genet Med Rep 2018;6:52-61.
83. Khan S, Ince-Dunn G, Suomalainen A, Elo LL. Integrative omics approaches provide biological and clinical insights: examples from
mitochondrial diseases. J Clin Invest 2020;130:20-8.
84. Mascalchi M, Montomoli M, Guerrini R. Neuroimaging in mitochondrial disorders. Essays Biochem 2018;62:409-21.
85. Gropman AL. Neuroimaging in mitochondrial disorders. Neurotherapeutics: the journal of the American Society for Experimental.
NeuroTherapeutics 2013;10:273-85.
86. Saneto RP, Friedman SD, Shaw DWW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396-413.
87. Ahmad K, Tan K, Sue C. The neuro-ophthalmology of mitochondrial disease with a particular focus on the morphology of the optic nerve
head. J Clin Neurosci 2014;21:2043.
88. Finsterer J, Frank M. Gastrointestinal manifestations of mitochondrial disorders: a systematic review. Therap Adv Gastroenterol
2017;10:142-54.